OGC
LUMO

One68 Global Capital’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

One68 Global Capital’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$209K Buy
+5,855
New +$101K 0.42% 51

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

One68 Global Capital's LUMO Position: Q4 2020 in Review

One68 Global Capital opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2020: 5,855 shares worth $209K. The stake represents 0.42% of the portfolio and ranks #51 among its holdings.

47 funds tracked by Wall St. Rank hold LUMO as of Q4 2020.

  • One68 Global Capital held 5,855 shares of Lumos Pharma, Inc. Common Stock worth $209K as of Q4 2020.
  • Lumos Pharma, Inc. Common Stock was a new One68 Global Capital position in Q4 2020.
  • Lumos Pharma, Inc. Common Stock made up 0.42% of One68 Global Capital's portfolio in Q4 2020, its #51 holding.
  • 47 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.